Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia

Urology

Volumn 49, Issue 5, 1997, Pages 692-696

  Wiley, Elizabeth L ^a,b,c   Davidson, Peter ^a,b,c   McIntire, Donald D ^a,b,c   Sagalowsky, Arthur I ^a,b,c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b St George's Hospital   (New Zealand)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY; TUMOR VOLUME;

AGED; CYSTECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030955099     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00627-9     Document Type: Article

References (24)

1. McNeal JE, and Bostwick DG: Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 17: 64-71, 1986.
2. Epstein JI, Grignon DJ, Humphrey PA, McNeal JE, Sesterhenn IA, Troncoso P, and Wheeler TM: Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 19: 873-886, 1995.
3. Drachenberg CB, and Papadimitriou JC: Aberrant pattern of lectin binding in low and high grade prostatic intraepithelial neoplasia. Cancer 75: 2539-2544, 1995.
4. Myers RB, Oelschlager D, Srivastava S, and Grizzle WE: Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. Prostate 25: 243-248, 1994.
5. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, and Buttyan R: Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol 143: 390-400, 1993.
6. Lieber MM: DNA ploidy in prostate cancer: potential measurement as a surrogate endpoint biomarker. J Cell Biochem Suppl 19: 246-248, 1994.
7. Amin MB, Schultz DS, Zarbo RJ, Kubus J, and Shaheen C: Computerized static DNA ploidy analysis of prostatic intraepithelial neoplasia. Arch Pathol Lab Med 117: 794-798, 1993.
8. Crissman JD, Sakr WA, Hussein ME, and Pontes JE: DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 22: 155-162, 1993.
9. Nagle RB, Petein M, Brawer M, Bowden GT, and Cress AE: New relationships between prostatic intraepithelial neoplasia and prostatic carcinoma. J Cell Biochem Suppl 16H: 26-29, 1992.
10. Myers RB, Srivastava S, and Grizzle WE: Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma. J Urol 153: 1572-1574, 1995.
11. Brenner PC, Rettig WJ, Sanz-Moncasi MP, Reuter V, Aprikian A, Old LJ, Fair WR, and Garin-Chesa P: TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. J Urol 153: 1575-1579, 1995.
12. Boag AH, and Young ID: Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am J Pathol 144: 585-591, 1994.
13. Ibrahim GK, MacDonald JA, Kerns BJ, Ibrahim SN, Humphrey PA, and Robertson CN: Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues. Surg Oncol 1: 151-155, 1992.
14. Nagle RB, Brawer MK, Kittelson J, and Clark V: Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 138: 119-128, 1991.
15. Mehlhorn J: Zur diagnostischen Wertigkeit "dysplastischer" Veranderungen der Prostata. Zentralbl Pathol 137: 395-401, 1991.
16. Sakr WA, Haas GP, Cassin BF, Pontes JE, and Crissman JD: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150: 379-385, 1993.
17. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, and Haas GP: High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8: 439-443, 1994.
18. Qian J, and Bostwick DG: The extent of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Mod Pathol 7: 81A, 1994.
19. Maygarden SJ, Novotny DB, Moul JW, Bae VL, and Ware JL: Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol 7: 930-936, 1994.
20. de la Torre M, Haggman M, Brandstedt S, and Busch C: Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy. Br J Urol 72: 207-213, 1993.
21. Weinstein MH, and Epstein JI: Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol 24: 624-629, 1993.
22. Ellis WJ, and Brawer MK: Repeat prostate needle biopsy: who needs it? J Urol 153: 1496-1498, 1995.
23. Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, and Lange PH: Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 38: 103-107, 1991.
24. Keetch DW, Humphrey P, Stahl D, Smith DS, and Catalona WJ: Morphometric analysis and clinical follow up of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 154: 347-351, 1995.